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Enantioselective transformation 
of fluoxetine in water and its 
ecotoxicological relevance
María Jesús Andrés-Costa1,2, Kathryn Proctor2, Marco T. Sabatini2, Anthony P. Gee2, Simon E. 
Lewis2, Yolanda Pico1 & Barbara Kasprzyk-Hordern2
European legislation focusing on water quality is expected to broaden to encompass several 
pharmaceuticals as priority hazardous substances. This manuscript aims to challenge current regulatory 
approaches that do not recognize stereochemistry of chiral pharmaceuticals by testing the hypothesis 
that environmental transformation and effects of chiral pharmaceuticals are stereoselective. Our 
experiments revealed that, while degradation of chiral fluoxetine (FL) in river water occurs via non-
enantioselective photochemical and mildly-enantioselective microbial processes favoring the (R)-
enantiomer, a pronounced enantioselectivity favoring (S)-FL (leading to the formation of (S)-NFL 
(norfluoxetine)) is observed during activated sludge treatment. Toxicity tests proved strong enantiomer-
specific toxicity in the case of Tetrahymena thermophila, protozoa that are utilized during activated 
sludge treatment ((R)-FL is 30× more toxic than (S)-FL; (S)-NFL is 10× more toxic than (S)-FL). This is 
of paramount importance as preferential degradation of (S)-FL in activated sludge microcosms leads 
to the enrichment of FL with 30× more toxic (R)-FL and formation of 10× more toxic (S)-NFL. It is 
commonly assumed that a decreased concentration of FL leads to decreased biological impact. Our 
study proves that despite the overall decrease in FL concentration, accumulation of toxic (R)-FL and 
formation of toxic (S)-NFL leads to much higher than presumed toxicological effects.
Pharmaceuticals are a group of pollutants with growing evidence regarding their environmental impacts. 
European legislation focusing on water quality is expected to broaden to encompass several pharmaceuticals as 
priority hazardous substances. This manuscript challenges current regulatory approaches that do not recognize 
stereochemistry of chiral pharmaceuticals. Fluoxetine (FL, known as Prozac) is used here as an example.
FL is a diphenhydramine derivative and selective serotonin reuptake inhibitor (SSRI). It is used to treat a 
variety of mental health problems such as depression, panic, anxiety, or obsessive-compulsive symptoms. There 
was a 165% increase in the prescribing of antidepressant drugs in England between 1998 and 2012 (an average of 
7.2% per year)1. Indeed, FL is the fourth most prescribed antidepressant in England, and accounts for 11.3% of 
all antidepressant drug use2.
FL is extensively metabolized to norfluoxetine (NFL) and several other metabolites such as FL glucuronide, 
NFL glucuronide, para-trifluoromethylphenol and hippuric acid. The principal metabolite, NFL, is formed by 
N-demethylation of FL. The potency and selectivity of NFL’s SSRI activity is similar to that of the parent drug. The 
elimination of FL accounts for 80% excreted in the urine (as 11.6% FL, 7.4% FL glucuronide, 6.8% NFL, 8.2% NFL 
glucuronide, >20% hippuric acid, 46% other) and approximately 15% excreted in the feces3.
Recent research studies have shown that most pharmaceuticals, including FL and NFL, enter the aquatic envi-
ronment via (un)treated communal wastewater. Both FL and NFL have been detected in wastewater and receiving 
waters at levels ranging from ng L−1 to μg L−1 4–14. Furthermore, they were found in the tissue of fish collected near 
municipal wastewater discharges. Both FL and NFL remain biochemically active in the environment and can have 
marked effects on the morphology, physiology, and behavior of different species6,10,15–18.
Despite some limited research on fate and effects of FL, there has been very little attention paid to the stereo-
chemistry of FL and its possible environmental impacts. FL has one chiral carbon in its structure and as a result 
it exists in two enantiomeric forms as (S)-FL and (R)-FL. Similarly, NFL exists in two enantiomeric forms as 
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(S)-NFL and (R)-NFL. Enantiomers of the same drug have identical physicochemical properties but may differ in 
their biological properties. Thus, chiral drugs can undergo stereoselective mechanisms controlling their fate such 
as distribution, metabolism and excretion, as these processes (due to stereoselective interactions of enantiomers 
with biological systems) usually favor one enantiomer over the other. This leads to process-dependent changes 
in the enantiomeric composition of chiral compounds9. Metabolism of FL was found to be enantioselective in 
humans, with the (R)-enantiomer being metabolized faster than (S)-enantiomer19. Additionally, due to different 
pharmacological activity, enantiomers of chiral drugs can differ in their biological actions, potency and toxicity20. 
Enantiomers of FL have similar potency as inhibitors of the serotonin reuptake pump in humans whereas enanti-
omers of NFL act differently, with (S)-NFL showing higher inhibition capacity21.
Ecotoxicity of FL (and other pharmaceuticals) is currently assessed for the racemate, as FL is marketed as a 
racemic mixture of two enantiomers. Environmental risk assessment (ERA) approaches need to be re-evaluated 
as they are based on a simplistic assumption that FL present in the environment is racemic9. Indeed, limited 
research indicates that FL and NFL are present in the aqueous environment as non-racemic mixtures, i.e. 
enriched with one enantiomer5,22–26. Furthermore, FL was found to undergo enantioselective transformation 
during wastewater treatment5,27. In a recent study, Barclay et al. (2011) found a slight enrichment of FL and 
NFL with (S)-enantiomer in both raw and treated wastewater22. In contrast, MacLeod et al. (2007) reported that 
in their monitoring study FL was enriched with (R)-enantiomer in wastewater indicating faster degradation of 
(S)-enantiomer during wastewater treatment5,23. Ribeiro et al.28 did not observe enantioselectivity in fluoxetine’s 
biodegradation in activated sludge. However, the same group observed enantioselective degradation favouring 
(R)-FL by Labrys portucalensis strain F1129.
FL is often used as a model compound for assessing SSRI impact on aquatic organisms such as zebraf-
ish, Japanese medaka, goldfish, gulf toadfish, rainbow trout, fathead minnows and polychaete worms 
(Capitella teleta)30–36. FL was reported as toxic at low concentrations to several aquatic species30,37–39 but 
enantiomer-dependent toxicity was not considered. In fact, FL was proposed as one of 10 pharmaceuticals poten-
tially dangerous for the environment5. Enantioselective toxicity of FL was demonstrated for Primephales prome-
las and Tetrahymena thermophila, where (S)-FL was found to be more toxic than its respective enantiomer34,38. 
On the other hand (R)-FL was considered more harmful to Pseudokirchneriella subcapitata38. To the authors’ 
knowledge, there are no published reports on NFL toxicity to aquatic organisms at enantiomeric level. NFL was 
reported to be more active in humans than the parent compound40. Fuller et al.21 determined that enantiomers of 
NFL have markedly different potencies as inhibitors of the uptake of serotonin with (S)-NFL being more potent 
than the (R)-enantiomer in rats. It is therefore expected that NFL’s ecotoxicity to aquatic organisms might also be 
enantiomer-dependent.
The above discussion clearly indicates that current ERA approaches that do not recognize stereochemistry of 
chiral pharmaceuticals are inaccurate and could lead to incorrect conclusions being drawn regarding the ecotox-
icological effects of chiral drugs. The limited work in the area of stereochemistry-induced fate and effects of FL 
(and pharmaceuticals in general) is mainly due to lack of enantioselective analytical methods as well as availabil-
ity of (affordable) enantiomerically pure analytical standards. Such analytical methods and affordable enantiom-
erically pure standards are essential to gather accurate data needed for comprehensive ERA of these compounds.
The overarching aim of this study was to verify, for the first time, enantiomer-dependent fate and ecotoxico-
logical effects of FL and its main metabolite NFL in the aquatic environment. To achieve the aim, the key compo-
nents of this study were:
 i) To synthesize single enantiomers of FL and NFL.
 ii) To develop an analytical method for the detection and quantification of enantiomers of FL and NFL utiliz-
ing chiral liquid chromatography coupled with tandem mass spectrometry.
 iii) To undertake, for the first time, mechanistic study of the degradation of FL and NFL formation in con-
trolled river water and activated sludge simulating microcosm experiments.
 iv) To verify, for the first time, enantiomer-specific toxicity of FL and NFL in aquatic species.
Results
Synthesis of enantiomerically pure FL and NFL enantiomers. Lack of commercially available and 
affordable enantiomerically pure standards is the key factor hindering progress in the understanding of bio-phys-
icochemical processes governing the fate and effects of chiral pharmaceuticals and the resulting environmen-
tal risks. To overcome this limitation and to enable toxicity studies on single-enantiomer drugs, we propose a 
conceptually straightforward approach. For any given drug of interest, our approach relies on taking a known 
chemical synthesis of the racemic form (for example, from the patent literature), and carrying out the same pro-
cedure, yet employing a single enantiomer of starting material. This removes the need to develop new synthetic 
procedures and allows for the rapid and cost-effective production of single enantiomer drug substance on a scale 
sufficient to enable toxicity studies. Careful choice must be given to the selection of the most appropriate literature 
synthesis, since the concept is not universally applicable – in some instances, a synthetic procedure might induce 
unwanted racemisation of one of the synthetic intermediates en route to the final drug substance. Nevertheless, in 
the case of FL and NFL, we have established a synthetic protocol that allows access to single enantiomers of NFL 
and FL, in just 3 or 4 synthetic steps, respectively. The single enantiomer starting material required (1) is com-
mercially available in both the (R) and (S) forms (99% e.e.), and the cost is not prohibitive. Our protocol draws on 
multiple literature sources, as shown in Fig. 1. Thus, from single enantiomer starting material 1, as per one of the 
original patents on fluoxetine41, reaction with potassium phthalimide affords single enantiomer 2, which in turn 
undergoes hydrazinolysis to give single enantiomer 3. Primary amine 3 can then be employed in a SNAr reaction 
to give single enantiomer NFL. Various synthetic procedures are reported for the conversion of NFL into FL; we 
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opted to employ carbamate formation followed by hydride reduction to convert a proportion of our synthesized 
NFL into FL42. By the above means we were able rapidly to access the required quantities of single enantiomer 
material to carry out the studies detailed below.
Enantioseparation of FL and NFL enantiomers with chiral LC-MS/MS. Unavailability of analytical 
methods allowing for enantiomeric separations of trace concentrations of chiral drugs in complex environmen-
tal matrices is a limiting factor hindering progress in fundamental understanding of their fate and effects. We 
therefore developed a robust, sensitive and selective method utilizing chiral liquid chromatography coupled with 
tandem mass spectrometry for enantiomeric separation of FL and NFL. We used Astec Chirobiotic V (CBV) col-
umn with mobile phase (pH 6.5, 0.06 mL min−1, 25 °C) composed of 70% of ethanol (EtOH), 30% of ultra-pure 
water (HQ water), 4 mM of ammonium acetate (AAC) and 0.005% of formic acid (FA) under isocratic conditions 
to achieve baseline separation of enantiomeric pairs (Fig. 2, Rs (resolution of enantiomers) = 1.41 and 1.00 for 
FL and NFL‚ respectively). All conditions tested and results can be found in Table S1 in the supplementary infor-
mation section. The method showed good linearity (R2 > 0.99) for all four enantiomers within the studied range 
(0.5–100 µg L−1). Method detection and quantification limits (MDLs and MQLs) for river water matrices ranged 
from 1.2 to 1.3 ng L−1 and from 4.6 to 5.1 ng L−1, respectively. In the case of activated sludge matrices, MDLs 
ranged from 0.4 to 0.8 ng L−1 and MQLs ranged from 1.7 to 3.1 ng L−1 (Table S2). The accuracy and precision 
were within ±20% (Table S3). Very good recoveries accounting for >67% were observed in the case of all four 
enantiomers in all studied matrices. Matrix effect (ME) accounted for <15.6%.
Figure 1. Synthesis of single enantiomers of NFL and FL. Reagents and conditions: (a) 1.2 equiv. potassium 
phthalimide, DMF, 90 °C, 2 h, 88%. (b) 3 equiv. NH2NH2.H2O, ethanol (EtOH), reflux, 2 h, 85%. (c) 1.5 equiv. 
sodium hydride, 1 equiv. p-fluorobenzotrifluoride, DMSO, 1 h, 90 °C, 71%. (d) 1.1 equiv. methyl chloroformate, 
5 equiv potassium carbonate, CH2Cl2/H2O 1:2, 20 min, room temp., then 2 equiv. lithium aluminium hydride, 
THF, 2 h, reflux, 80%.
Figure 2. Chromatographic separation of enantiomers of FL and NFL.
www.nature.com/scientificreports/
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Synthesized enantiomerically pure FL and developed chiral LC-MS/MS method were used to verify transfor-
mation of FL in river and activated sludge simulating microcosms and their ecoxoticological impacts.
Transformation of FL and NFL in river and activated sludge simulating microcosms. River water 
microcosms. The river simulating microcosms revealed that degradation of FL takes place via both microbial 
and photochemical processes (Fig. 3 and Table S4). Photolysis is considered to be the most important phenome-
non contributing to the degradation of FL, as 74.5% (S)-FL and 79.2% (R)-FL of FL were removed in light abiotic 
conditions (LAR). This process, as expected, was found not to be enantioselective. Microbial processes resulted 
in mild enantioselectivity towards (R)-enantiomer and led to the removal of 60.4% of (S)-FL and 67.9% of (R)-FL 
at dark biotic conditions (DBR). As expected, the light biotic reactor (LBR) utilizing both photochemical and 
microbial processes led to the highest removal of FL: 98.4% of (S)-FL and 96.7% of (R)-FL. Dark abiotic condi-
tions (DAR) did not lead to any significant removal of FL. Traces of NFL were observed in both abiotic and biotic 
conditions (Figure S1). This indicates that degradation of FL leading to NFL formation takes place as a result of 
both photochemical and microbial processes.
Activated sludge microcosm. Transformation of FL in activated sludge simulating microcosms was studied at two 
concentration levels: 10 and 100 µg L−1 of racemic FL (Fig. 4 and Table S5). In both cases a significant decrease in 
the concentration of (S)-FL and (R)-FL was observed. In the microcosm spiked with 10 µg L−1 rapid removal of 
FL occurred during the first 30 minutes (50% degradation). This process was not stereoselective (enantiomeric 
fraction (EF) 0.5) and did not lead to expected formation of NFL. It is therefore postulated that this high rapid 
removal of FL from the aqueous phase during the first 30 min of the experiment is due to its sorption to sus-
pended particulate matter. Further removal of FL in 10 µg L−1 reactor was much slower and led to its stereoselec-
tive transformation favoring (S)-FL (EF < 0.3) and leading to the formation of NFL enriched with (S)-enantiomer 
(EF > 0.7). As the activated sludge simulating microcosms were undertaken in the dark, it is postulated that 
observed stereoselective transformation of FL and stereoselective formation of NFL is due to the prevalence of 
stereoselective microbial metabolic processes in studied bioreactors. Molar percentage yield of NFL formation 
denoted: 10.7% and 6.2% for (S)-FL and (R)-FL‚ respectively.
Similar observations were recorded in the microcosm spiked with 100 µg L−1 of FL. However, the effect of 
sorption was not observed. This is probably due to much higher initial FL load in 100 µg L−1 bioreactor not allow-
ing for the change to be recorded. Stereoselective microbial processes resulted in 60% transformation of FL with 
Figure 3. Degradation of FL in river water simulating microcosms under dark abiotic (DAR), dark biotic 
(DBR), light abiotic (LAR) and light biotic (LBR) conditions (concentrations are represented by bars, 
enantiomeric fractions are represented by symbols).
www.nature.com/scientificreports/
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twice as high preference towards (S)-FL (EF < 0.3, 80% removal of (S)-FL and only 38% removal of (R)-FL) and 
formation of NFL enriched with (S)-enantiomer (EF > 0.7). Molar percentage yield of NFL formation denoted: 
11.7% and 7.4% for (S)-FL and (R)-FL. This is in agreement with results obtained for 10 µg L−1 bioreactor. 
Interestingly in both bioreactors, long lag phases (3 h and 2 h in the case of 10 µg L−1 and 100 µg L−1 FL bioreactor‚ 
respectively) were observed.
Kinetic studies (Table 1) confirmed low biodegradation of FL and the more recalcitrant nature of (R)-FL. kbiol 
and t1/2biol of (S)-FL transformation were 0.04 LgSS−1h−1 and 19 h respectively in both 10 and 100 µg L−1 bioreac-
tors. kbiol and t1/2biol of (R)-FL transformation were much lower and denoted 0.01 LgSS−1h−1 and 68 h respectively 
in 100 µg L−1 bioreactors. Due to the lack of degradation of (R)-FL in 10 µg L−1 bioreactor, no kinetic studies could 
be undertaken.
Figure 4. Degradation of FL and formation of NFL in activated sludge simulating microcosms under dark 
biotic (DBR) conditions (concentrations are represented by bars, enantiomeric fractions are represented by 
symbols).
R2 SS [g L−1] k1 [h−1] t1/2 [h] kbiol [LgSS−1h−1] t1/2biol [h]
10 µg L−1
(S)-FL y = −0.0715x - 0.0584 0.8696 2.0 0.07 9.69 0.04 18.9
(R)-FL No degradation   n/a  n/a  n/a  n/a  n/a  n/a
100 µg L−1
(S)-FL y = −0.0721x - 0.0667 0.8216 2.0 0.07 9.61 0.04 19.4
(R)-FL y = −0.0206x - 0.0274 0.8202 2.0 0.02 33.6 0.01 68.0
Table 1. Degradation pseudo-first order rate constants (k1 and kbiol) in single-compound activated sludge 
simulating microcosm. n/a - not calculated due to no degradation of (R)-(−)-enantiomer.
www.nature.com/scientificreports/
6Scientific REPoRtS | 7: 15777  | DOI:10.1038/s41598-017-15585-1
The results above indicate that longer sludge retention times might be needed during wastewater treatment 
in order to facilitate degradation of FL. However, it should be noted that these processes are likely to be stereose-
lective and could potentially lead to enrichment of FL with the more potent enantiomer, as well as formation of 
biologically active metabolites; this is despite the nominal decrease in concentration levels of FL.
Ecotoxicity of FL and NFL. Enantiomer-dependent toxicity of FL and NFL was evaluated for two aquatic 
organisms: Daphnia magna and Tetrahymena thermophila. EC5048h for FL enantiomers towards D. magna was 
3.6 mg L−1 and 4.1 mg L−1 for (S)-FL and (R)-FL respectively (Table 2). EC5048h for NFL towards D. magna 
denoted 2.8 mg L−1 and 2.9 mg L−1 for (S)-NFL and (R)-NFL (raw data are shown in Table S6). The results indicate 
a noticeable difference between the toxicity of FL and NFL, NFL being more toxic than FL, but no significant 
enantioselectivity was observed for studied enantiomeric pairs. In contrast, EC5024h for FL enantiomers towards 
T. thermophila was strongly enantiomer dependent and denoted 35.3 mg L−1 and 1.3 mg L−1 for (S)-FL and 
(R)-FL‚ respectively. These results contradict those published by De Andrés et al.38 as within that study it was 
observed that the (S)-enantiomer was more toxic with an EC5024h of  3.2 mg L−1 compared to the (R)-enantiomer 
with an EC5024h  30.5 mg L−1. To confirm the validity of measurement undertaken in this work, the stock solutions 
and the test cells were analyzed with the chiral-LC-MS/MS method. The results showed that the changes in the 
concentrations of the toxicants were minimal during the test, however they support the use of the correct enanti-
omer in this test. This was further confirmed by the use of enantiomerically pure analytical standards to confirm 
the retention time of each enantiomer (Figure S2).
Similarly to FL, EC5024h for NFL enantiomers towards T. thermophila was strongly enantiomer dependent. 
The EC5024h for NFL denoted 3.8 mg L−1 and 5.8 mg L−1 for (S)-NFL and (R)-NFL‚ respectively. Unlike FL, the 
(S)-NFL is more toxic than (R)-NFL. This is of paramount importance as preferential degradation of less toxic 
(S)-FL in activated sludge microcosms leads to the formation (and accumulation) of more toxic (S)-NFL. This is 
also an important consideration as T. thermophila is part of the microbial community of activated sludge (EC5024h 
data for T. thermophila is shown in Fig. 5 and Tables S7–S14).
Discussion
This report is, to the authors’ knowledge, the first to study transformation of FL in environment simulating micro-
cosms combined with ecotoxicological effects. The research reported in this manuscript tested and validated the 
hypothesis that degradation of FL, and formation of its main metabolite NFL, are enantioselective and biological 
in nature, and that their toxicity is enantiomer-dependent.
Organism Test Toxicity endpoints
Effect [mg L−1]
Ref
FL NFL
(S)- (R)- (S)- (R)-
P. promelas
LOEC7d
-survival 0.10 0.17 n/a n/a 34
-growth 0.05 0.17 n/a n/a
-feeding 0.05 0.17 n/a n/a
LC5048h -survival 0.22 0.21 n/a n/a 34
D. magna
LOEC21d
-immobilization 0.44 0.43 n/a n/a 34
-reproduction 0.44 0.43 n/a n/a
-grazing 0.20 none n/a n/a
LC5048h -immobilization 6.9 8.1 n/a n/a 38
EC5048h -immobilization 3.6 4.1 2.8 2.9 (this study)
T. thermophila
EC5024h -growth 3.2 30.5 n/a n/a 38
EC5024h -growth 35.2 1.3 3.8 5.8 (this study)
Table 2. Ecotoxicity of FL and its metabolite NFL (n/a – not analysed).
Figure 5. EC5024h for the T. thermophila test. See Tables S7–14 for CV% of individual tests.
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The river simulating microcosms revealed that degradation of FL takes place via both microbial and pho-
tochemical processes. Non-stereoselective photolysis was observed to be the most important phenomenon 
contributing to the degradation of FL. Microbial processes resulted in only mild enantioselectivity towards the 
(R)-enantiomer. However, a pronounced stereoselectivity was observed during activated sludge simulating micro-
cosms. Microbial metabolic processes of FL during activated treatment process favored the (S)-enantiomer, which 
led to the enrichment of FL with the (R)-enantiomer. This is in contrast to metabolic processes in humans, which 
favor the (R)-enantiomer and lead to enrichment of FL in urine with the (S)-enantiomer19. The outcomes of 
human metabolism studies as well as full scale and microcosm wastewater treatment measurements indicate that 
enantiomeric signature of FL can change subject to composition and structure of microbial communities present 
in wastewater. Indeed in our full scale untreated wastewater study, FL was enriched with the (S)-enantiomer 
(EF 0.7)43. This confirms, yet again, complexity of environmental processes and reinforces the need for further 
comprehensive studies focusing on transformation of chiral pollutants in the environment.
Toxicity tests showed that while there is no significant enantioselectivity in the toxic response from D. magna 
to both FL and NFL, a strong enantiomer-dependent toxicity is observed in the case of T. thermophila ((R)-FL 
30× higher than (S)-FL and (S)-NFL 10× higher than (S)-FL).
The above results indicate that traditional toxicological studies that do not recognize the importance of ste-
reochemistry might not reveal the true toxicological impact resulting from stereochemistry of chiral drugs. Our 
research indicates that (S)-FL is preferentially degraded in activated sludge microcosms. This is expected, as 
(S)-FL is the least toxic to protozoa (organisms that are known to be key contributors to activated sludge treat-
ment process) out of all four FL/NFL enantiomers studied. Unfortunately, this also indicates that FL, due to pref-
erential metabolic degradation of (S)-FL, gets enriched with more toxic (R)-FL and leads to the formation of more 
toxic (S)-NFL. This accumulation of toxic (R)-FL and (S)-NFL will have detrimental effects on the performance 
of activated sludge treatment processes.
This study revealed that there are several, unaccounted for, underlying issues in both exposure and hazard 
assessment within ERA of chiral pharmaceuticals. One can assume that, if the stereochemistry of FL is not con-
sidered, decreased concentration of FL as a result of activated sludge treatment leads to decreased biological 
impact. Such an approach (as currently applied in ERA) can lead to false conclusions impacting environmental 
health. Our study proves that despite the overall decrease in FL concentration, accumulation of toxic (R)-FL and 
formation of toxic (S)-NFL in activated sludge will likely lead to higher toxicological effects, as observed in the 
case of protozoa. The European Medicines Agency guideline on the ERA of Medicinal Products for Human Use44 
and the EU Directive for ERA for Veterinary Medicinal Products45 recommend the estimation of exposure and 
the prediction of risk calculation for the whole parent compounds only i.e. as a racemate or a mixture of stereoi-
somers if distributed as such. Therefore, current ERA leads to under or overestimation of toxicity of chiral phar-
maceuticals and to incorrect ERA as chiral pharmaceuticals are present in the environment in their non-racemic 
forms and they show enantiomer-specific biological effects. We therefore recommend the adoption of a new 
strategy within ERA acknowledging stereochemistry of studied targets.
Methods
Chemicals and materials. HPLC-grade methanol (MeOH), EtOH, AAC, (99%), FA (98%) were purchased 
from Sigma Aldrich (Cambridge, UK). HQ water was supplied by a Milli-Q system (PURELAB, Elga, UK).
The reference standards, rac-FL and rac-NFL and the internal standard (IS) FL-d5 were purchased from LGC 
Standards (Teddington, UK). All standards and ISs were of the highest purity available (>97%). Structures, 
molecular formulae and molecular weights of target enantiomers are summarized in Table S15.
Stock solutions of the individual compounds were purchased in MeOH at a concentration of 1 mg mL−1 or 
0.1 mg mL−1 and stored in the dark at −16 °C. Working solutions were prepared by diluting stock solutions in 
mobile phase or MeOH on a daily basis and stored at 4 °C.
All glassware was deactivated with dimethyldichlorosilane (5% DMDCS in toluene, Sigma-Aldrich) to 
minimize sample loss through adsorption of basic analytes onto –OH sites present on the glass surface46. Oasis 
HLB (60 mg, 3 mL, Waters, UK) were used for solid phase extraction (SPE). HQ water, river water (collected in 
South-West England) and activated sludge (collected from a local wastewater treatment plant) were used for 
method development and validation.
Synthesis of FL and NFL enantiomers. This procedure employs 3-chloro-1-phenyl-1-propanol as start-
ing material and source of chirality. This was purchased from Sigma-Aldrich chemical company: (R)-enantiomer 
product #338419; (S)-enantiomer product #324612. Both were certified as having 99% enantiomeric excess. 
Experimental procedures are described for the (R)-enantiomer; identical procedures were carried out with the 
(S)-enantiomer of starting material to synthesize (S)-NFL and (S)-FL.
Step 1: (R)-3-phthalimido-1-phenylpropanol (2). At room temperature, to a stirring suspension of potassium 
phthalimide (3.93 g, 21.25 mmol) in dry dimethylformamide (DMF) (115 mL) was added (R)-3-chloro-1-phenyl-
1-propanol 1 (3.00 g, 17.65 mmol) in dry DMF (5 mL). The reaction mixture was heated to 90 °C and left to stir for 
2 hours, until completion was observed by thin layer chromatography (TLC.) To the cooled reaction mixture was 
added H2O (300 mL), and extracted with diethyl ether (2 × 300 mL). The combined organic extracts were washed 
with a saturated solution of LiCl (300 mL), brine (300 mL), dried over MgSO4 and filtered. The filtrate was concen-
trated in vacuo to give (R)-3-phthalimido-1-phenylpropanol 2 as a white powder (4.30 g, 88%); mp 78–79 °C; Rf 
0.36 (3:1 Petrol/ethyl acetate). δH (250 MHz, CDCl3) 7.86–7.83 (2 H, m, ArH), 7.74–7.71 (2 H, m, ArH), 7.36–7.21 
(5 H, m, ArH), 4.69 (1 H, t, J 6.5 Hz, CHOH), 3.91 (2 H, t, J 6.5 Hz, CH2N), 2.13–2.05 (2 H, m, CH2CHOH); δC 
(300 MHz, CDCl3) 168.8, 143.5, 134.0, 131.9, 128.4, 127.4, 125.6, 123.3, 71.2, 37.6, 34.8 (Figure S3).
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Step 2: (R)-3-amino-1-phenyl-1-propanol (3). At room temperature, to a stirred solution of (R)-3-phthalimido-
1-phenylpropanol 2 (4.10 g, 14.5 mmol) in EtOH (90 mL) was added hydrazine hydrate (2.09 mL, 43.5 mmol). 
The reaction mixture was stirred for 1 hour and then heated to reflux for 2 hours. The reaction mixture became 
thick and cloudy upon heating, and when cooled, precipitate was filtered off. Recovered filtrate was concen-
trated under reduced pressure, diluted with dichloromethane (DCM) (10 mL) and filtered, washed with DCM 
(2 × 5 mL). The recovered filtrate was concentrated in vacuo to give the title compound (R)-3-amino-1-phenyl-
1-propanol 3 as a brown oil (1.85 g, 85%); Rf 0.09 (100:10:1 DCM/MeOH/ Et3N). δH (300 MHz, dimethylsulfoxide 
(DMSO-d6)) 7.34–7.27 (4 H, m, ArH), 7.24–7.17 (1 H, m, ArH), 4.66 (1 H, dd, J 7.0, 6.0 Hz Hz CHOH), 2.71–2.60 
(2 H, m, CH2N), 1.69–1.62 (2 H, m, CH2CHOH); δC (75 MHz, DMSO-d6) 146.6, 128.0, 126.6, 125.7, 71.3, 42.2, 
38.9 (Figure S4).
Step 3: (R)-3-Phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine•HCl [(R)-NFL hydrochloride salt]. At 
0 °C, to a stirred suspension of sodium hydride (60% in oil, 0.73 g, 18.34 mmol) in DMSO (3.0 mL) was added 
(R)-3-amino-1-phenyl-1-propanol 3 (1.85 g, 12.23 mmol) in DMSO (1.0 mL). The reaction mixture was stirred 
at 55 °C for 30 min and 4-fluorobenzotrifluoride (3.01 g, 18.34 mmol) in 1.85 mL DMSO was added dropwise. 
The resulting mixture was heated for 1 hour at 90 °C, until completion was observed by TLC. The mixture was 
cooled to 0 °C, and diluted with aqueous 1 N NaOH (20 mL). Toluene was used to extract the product (3 × 20 mL), 
and combined organic extracts were dried over MgSO4 and filtered. The crude product was purified by column 
chromatography (100:0:1 to 100:6:1 DCM/MeOH/Et3N) to give (R)-3-phenyl-3-[4-(trifluoromethyl)phenox-
y]-1-propanamine [(R)-NFL] as a brown oil (2.10 g, 58%). Product (1.0 g, 3.39 mmol) was dissolved in 4 M HCl in 
dioxane (10.0 mL, 40 mmol), and left to stir for 2 hours. Reaction mixture was concentrated in vacuo, and recrys-
tallized (50 mL of 3:2 diethyl ether/hexane) to give (R)-3-Phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine 
hydrochloride [(R)-NFL•HCl] as a white solid (0.80 g, 71%); mp 128–129 °C; Rf 0.04; δH (250 MHz, CDCl3) 8.45 
(3 H, br s, NH3) 7.39 (2 H, d, J 8.5 Hz, ArH), 7.27–7.32 (5 H, m, ArH), 6.91 (2 H, d, J 8.5 Hz, ArH), 5.42 (1 H, dd, 
J 7.5, 4.5 Hz, CHO), 3.18 (2 H, app t, J 5.5 Hz, CH2CH2NH), 2.47–2.27 (2 H, m, CH2N); δC (300 MHz, CDCl3): 
159.5, 139.0, 129.1, 128.4, 126.7 (q, 3JCF 3.8 Hz), 125.7, 124.2 (q, 1JCF 270 Hz), 123.3 (q, 2JCF 32.6 Hz), 115.9, 77.4, 
36.9, 36.0; νmax (film) 3385 (N-H), 2891 (C-H), 2015, 1613 cm−1; [α]D + 14.0° (c 1, CHCl3); for (S)-enantiomer: 
[α]D –15.0° (c 1, CHCl3) (Figure S5).
Step 4: (R)-N-Methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine [(R)-FL]. At room temperature, to a 
stirred solution of 3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine (R)-NFL (1.0 g, 3.38 mmol) and 
methyl chloroformate (0.29 mL, 3.72 mmol) in DCM (15.0 mL) was added aqueous K2CO3 (2.33 g, 16.89 mmol 
in 30 mL H2O). The reaction mixture was vigorously stirred for 20 minutes, until completion was observed 
by TLC, dyed with ninhydrin. The organic phase was separated and the aqueous phase extracted with DCM 
(2 × 30 mL). The combined organic extracts were dried over MgSO4 and filtered. The filtrate was concentrated 
in vacuo to yield intermediate carbamate as a pale yellow oil. At 0 °C, to a stirring suspension of LiAlH4 (0.25 g, 
6.59 mmol) in dry tetrahydrofuran (THF) (15.0 mL) was added dropwise a solution of the intermediate car-
bamate in dry THF (5.0 mL). The reaction mixture was gradually heated to reflux for 2 hours. To the cooled 
mixture were cautiously added 0.25 mL of water, followed by 0.25 mL of 2 N NaOH, and 0.75 mL of water, in 
that order. The solution was dried over MgSO4 and filtered. The filtrate was concentrated over reduced pressure, 
and the crude product was purified by column chromatography (100:0:1 to 100:1:1 EtOAc/MeOH/Et3N) to give 
(R)-N-Methyl-3-(4-trifluoromethylphenoxy)-3-phenylpropylamine [(R)-FL] as a pale yellow oil (0.84 g, 80%); Rf 
0.09 (100:1:1 EtOAc/MeOH/Et3N); δH (300 MHz, CDCl3) 7.43 (2 H, d, J 8.5 Hz, ArH), 7.34–7.23 (5 H, m, ArH), 
6.90 (2 H, d, J 8.5 Hz, ArH), 5.31 (1 H, dd, J 8.0, 4.5 Hz, CHO), 2.82–2.66 (2 H, m, CH2CH2NH), 2.44 (3 H, s, 
CH3), 2.27–2.16 (1 H, m, CHHN), 2.08–1.97 (1 H, m, CHHN), 1.69 (1 H, br. s, NH); δC (300 MHz, CDCl3) 160.5, 
141.0, 128.8, 127.8, 126.7 (q, 3JCF 3.8 Hz), 125.7, 115.7, 78.5, 48.2, 38.6, 36.4 (signals for -CF3 and C-CF3 were not 
observed); νmax (film) 3033 (ArC-H), 2937 (ArC-H), 2846 (C-H), 2796, 1614 cm−1; [α]D + 3.0° (c 1, CHCl3); for 
(S)-enantiomer: [α]D – 3.0° (c 1, CHCl3) (Figure S6).
Microcosm bioreactors. River water simulating microcosms. River water microcosm experiments were 
conducted in light (L) and dark (D) conditions, and biotic (B) or abiotic (A) conditions with or without sodium 
azide (an inhibitor of microbial processes) respectively as shown in Fig. 6. Four microcosm bioreactors were 
investigated in duplicate thus eight autoclaved conical flasks were used as bioreactors in microcosm experiments. 
Each bioreactor was filled with 2 L of river water collected from a local river and spiked with racemic standard of 
S/R (±) FL to obtain a final concentration of 1 µg L−1. Abiotic bioreactors were spiked with sodium azide at a con-
centration of 1 g L−1 to inhibit biotic processes. Two replicates of biotic and abiotic bioreactors were exposed to 
light and another two replicates of each bioreactor were kept in the dark. Light conditions were simulated with an 
Osram 400 W HQI BT daylight lamp during 8 h each day. Average photon flux measured at the level of the bottle 
base was 395 µmol m−2 s−1. Dark conditions were simulated covering up the flask with foil. Magnetic stirrers were 
used to ensure good mixing. The experiment was carried out during 16 days. Samples (50 mL each) were collected 
every day, with the exception of weekends. IS was added to each sample (to obtain a final concentration of 100 ng 
mL−1). Samples were then frozen to prevent compound degradation until their analysis.
Dissolved oxygen (DO), pH and temperature (T) were analyzed during sampling period and total suspended 
solids (TSS), NO2−, NH4, and chemical oxygen demand (COD) were analyzed at the beginning of the experimen-
tal period (Table S16).
Activated sludge simulating microcosms. Activated sludge microcosm experiments were conducted in the dark 
and aerobic conditions. Three microcosm bioreactors were investigated in duplicate. They were filled with 2 L of 
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fresh activated sludge collected from a local wastewater treatment plant. One bioreactor remained un-spiked and 
the other two bioreactors were spiked with a racemic standard of S/R (±) FL to obtain concentrations of either 
10 or 100 µg L−1. Dark conditions were simulated by covering up the flask with foil. Aerobic conditions were 
obtained using air from BOC air cylinder and a thorough mixing was maintained using magnetic stirrers. The 
experiment was 24 hours long. Samples (100 mL each) were taken at the following time intervals: 0, 0.5, 1, 1.5, 2, 
3, 5, 8, 12 and 24 h. After sample collection, IS was added to each sample to obtain a final concentration of 100 
ng mL−1. Collected samples were subsequently frozen until their analysis to prevent degradation of compounds.
DO, pH, T and TOC, were analyzed throughout the experimental period and TSS, NO3−, NO2−, NH4 and 
COD were analyzed at the beginning of the experiment at t = 0 min (Table S17).
Kinetics – activated sludge simulating microcosms. The compounds studied are characterized as having low vol-
atility and therefore volatilization was not considered as a potential removal pathway in studied microcosms. 
Photodegradation was also not considered (not relevant) under tested activated sludge conditions. Therefore 
the two important degradation mechanisms to consider were biodegradation and sorption to sludge. FL was 
reported to have high sorption affinity towards particulate matter47. However, in this study, sorption equilibrium 
was assumed and therefore sorption could be considered negligible. This is because sorption is assumed to be fast 
when compared to biological degradation48. Section “Activated sludge microcosm” confirms this hypothesis as FL 
in activated sludge microcosms remained constant in FL 100 µg L−1 microcosm during the first 2 h of the exper-
iment. In the case of FL 10 µg L−1, a significant drop of FL concentration took place during the first 0.5 h (likely 
due to sorption) and then remained stable during the first 3 h of the experiment, showing a significant lag phase.
Several reports utilized pseudo-first-order kinetics for degradation of micropollutants in activated sludge 
reactors48–50. Indeed when applying pseudo-first order kinetics (OECD 303) in this work, ln(Ce/Ci) plotted as a 
function of time yielded a straight line (R2 > 0.9). Pseudo-first order biodegradation rate k1 [L g−1h−1] (normal-
ised for concentration of suspended solids) was therefore calculated using the following formula (equation (1)):
= − ∗ ∗In C
C
k t SS
(1)
e
i
1
where: t = aeration time (24 h), Ce = concentration at time point t (µg L−1), Ci = initial concentration (µg L−1), 
SS = concentration of activated sludge solids (g L−1).
Analysis. Solid phase extraction. Samples (50 mL of river water and 100 mL of activated sludge) were fil-
tered using Whatman GF/F 0.7 µm glass fiber filter and passed through Oasis HLB cartridges (60 mg, 3 mL) 
pre-conditioned with 2 mL of MeOH and equilibrated with 2 mL of HQ water at a rate of 8 mL min−1. Samples 
were passed through the HLB cartridge at a rate of 8 mL min−1 and then dried under the vacuum for 30 min to 
dry out residual water. Analytes were eluted with 4 mL of MeOH at a rate of <1 mL min−1. Extracts were then 
evaporated to dryness with TurboVap evaporator (Caliper, UK, 40 °C, N2, <5 psi) and reconstituted in 0.5 mL of 
mobile phase. All samples were filtered through 0.2 µm PTFE filters (Whatman, Puradisc, 13 mm) and transferred 
to popylpropylene 0.3 mL capacity vials (Waters, UK).
SPE recoveries of FL and NFL in HQ water, river water and activated sludge were calculated as the ratio of the 
analyte peak area in the sample extract spiked with analytes before extraction (the peak area of analyte un-spiked 
sample extract was subtracted) to the analyte peak area in the non-extracted standard solution.
ME was calculated for each chiral drug as a percentage decrease or increase in signal intensity in a sample 
matrix versus HQ water using the following equation (2):
∆
∆
=ME matrix
HQ water (2)
Figure 6. Scheme of river and activated sludge simulating microcosms.
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where Δmatrix is the standard calibration graph slope in different matrix (river water or active sludge) and ΔHQ 
water is the standard calibration graph slope in HQ water.
Chiral-LC-MS/MS method. Chromatographic analysis was performed using an Acquity UPLC system (Waters, 
Manchester, UK) consisting of Acquity UPLC binary solvent manager and Acquity UPLC sample manager. To 
achieve suitable separation of FL and NFL and their two stereoisomers, two chiral columns, namely Chiralpak 
CBH (10 cm × 2.0 mm, 5 μm particle size) and Astec CBV (25 cm × 2.1 mm, 5 μm particle size) were screened.
Several mobile phases were tested in order to obtain chiral separation of FL and NFL using LC and to main-
tain satisfactory electrospray ionization (ESI) performance in the positive ionization mode. MeOH, EtOH and 
HQ water were used at different concentrations as the mobile phase solvents. Among the mobile phase additives, 
different concentrations of AAC (1, 4 and 10 mM), MeOH (85, 80 and 70%) and EtOH (70 and 80%) were tested 
to maximize the Rs of FL and NFL.
The composition of the mobile phase was optimized to enhance the chromatographic efficiency and resolution 
between the enantiomers. Rs was calculated using the following equation (3):
=
−
+
R tr tr
W W
2( )
(3)S
E E
E E
2 1
2 1
where trE1 and trE2 are the retention times of the first and the second eluted enantiomers, respectively, and WE1 
and WE2 are the widths of these responses at the base peak.
The best enantiomeric separation of the studied drugs was achieved with a mobile phase (pH 6.5) composed 
of 70% of EtOH, 30% HQ water, 4 mM of AAC and 0.005% of FA using an Astec CBV column. The separation of 
enantiomers of chiral pharmaceuticals was undertaken under isocratic conditions, with an injection volume of 
20 µL. The column was kept at 25 °C and the temperature in the sample manager was kept at 4 °C. The flow rate 
was 0.06 mL min−1, which gave an initial pressure of ~850 psi.
Identification and quantification of FL and NFL was undertaken with an Acquity Xevo TQD (Waters, 
Manchester, UK), a triple quadrupole MS equipped with an ESI source. The analyses were performed in pos-
itive mode with a capillary voltage of 3 kV, a source temperature of 150 °C and a desolvation temperature of 
250 °C. A cone gas flow of 50 L h−1 and desolvation gas flow of 450 L h−1 were used. Nitrogen, used as a nebulising 
and desolvation gas, was provided by a high purity nitrogen generator (Peak Scientific Instruments Ltd., UK). 
Argon (99.99%) was used as a collision gas. The mass spectrometer was operated in multiple reaction monitor-
ing (MRM) mode, measuring the fragmentation of the protonated pseudo-molecular ions of each compound. 
A dwell time of 20 ms per ion pair was optimized to maintain high sensitivity of the analysis. MassLynx v4.1 
(Waters, UK) software was used to collect and analyze the obtained data.
Quantifier and qualifier transitions were optimized for each compound based on the most intense signal. 
Specific parameters such as collision energy (CE) and cone voltage (CV) were optimized for FL, NFL and FL-d5 
separately in a continuous flow mode through direct injection of standard solution at a concentration of 50 µg L−1 
into the stream of the mobile phase. FL presents a precursor ion [M + H]+ m/z of 310.3 and a product ion of m/z 
44.2 (quantifier transition) with a CV of 34 and CE of 10 and m/z 148.2 (qualifier transition) with a CV of 25 
and CE of 8. NFL presents a precursor ion [M + H]+ m/z 298.4 and a corresponding product ions at m/z 134.1 
(quantifier transition) with a CV of 17 and CE of 7 and m/z 30 (qualifier transition) with a CV of 17 and CE of 7. 
FL-d5 presents a precursor ion [M − H]+ m/z 315.2 and a corresponding product ions at m/z 136.2 (quantifier 
transition) with a CV of 26 and CE of 71 and m/z 20.
Method validation parameters. A 10-point multi-component IS calibration curve was applied for quan-
tification of FL and NFL enantiomers. All instrumental and method validation parameters such as linearity and 
range, accuracy, precision, detection and quantification limits and calibration curve were determined for HQ 
water, river water and activated sludge spiked with known concentrations of chiral compounds.
Linearity and range of the analytical procedure were undertaken by serial dilution of stock solution 
(10 µg mL−1). Accuracy of the method was evaluated at three concentration levels (5, 25 and 250 µg L−1) as a 
percentage deviation from known added quantity of each enantiomer in the sample. Intra-day and inter-day 
precision was expressed by the relative standard deviation (RSD) of 3 replicate measurements at three different 
concentration levels (5, 25 and 250 µg L−1) on the same and three different days.
HQ water standard solutions were used for instrumental detection limit (IDL) and instrumental quantifica-
tion limit (IQL). The IQL was estimated for the concentration of a compound that gave a signal-to-noise ratio of 
10:1. The IDL corresponded to the concentration that gave a signal-to-noise of 3:1.
MDL and (MQL for river water and activated sludge were calculated using the following equations (4) and (5):
=
×
×
MDL IDL
Rec CF
100
(4)
S N/
=
×
×
MQLcalc IDL
Rec CF
100
(5)
S N/
where IDLS/N is the instrumental detection limit (µg L−1), IQLS/N is the instrumental quantification limit (µg 
L−1), Rec is the absolute recovery of the analyte (%) at 25 µg L−1, and CF is the concentration factor, which in this 
method denotes 200 for active sludge and 100 for river water.
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The EF of studied chiral drugs was calculated using the following equation (6):
=
+
EF S
S R
( )
( ) ( ) (6)
Where (S) and (R) are concentrations of the (S)- and (R)- enantiomers, respectively.
Toxicity tests. Daphnia magna acute 48 h immobilization assay. The D. magna bioassay was carried out 
using DaphtoxkitTM (Crustacean Toxicity Screening Test for Freshwater; Microbiotests, Nazareth, Belgium) fol-
lowing the standard operational procedure in accordance to the ISO standard 6341:2012 and the OECD 202 
guideline. Less than 24 h old daphnids were exposed to a series of concentrations of each enantiomer of FL and 
NFL. Six concentration levels (5 concentrations plus control, four replicate beakers for each concentrations, five 
individual for each beaker) were tested. The concentrations were from 0.5 to 50 mg L−1 for FL and NFL enantiom-
ers based on preliminary range finding tests. Each experiment was repeated in triplicate. After 48 h incubation, 
daphnids were observed and the mobile daphnids in each container were reported. The EC50 were calculated 
using 48 h results.
Tetrahymena thermophila chronic 24 h population growth assay. T. thermophila bioassay was carried out using 
Protoxkit F (Microbiotests, Ghent University, Belgium). The tests were performed in accordance with the proto-
cols provided by the manufacturer. Protoxkit F is a 24 h chronic population growth assay.
The tests were carried out in disposable spectrophotometric cells of 1 cm path-length, to enable the measure-
ment of the optical density (OD) at 440 nm. These measurements were taken at T0h and T24h, as well as two hour 
increments after initial 24 h incubation to monitor the change in turbidity of the sample. The reconstituted food 
substrate supplied with each test provides an initial high turbidity at T0h, which, in the control cells, drastically 
decreases over the next 24 h due to the uninhibited growth of the ciliate population. This change in OD over the 
time period is used to quantify the degree of inhibition and subsequent calculation of the EC50. Each concentra-
tion was repeated in duplicate.
The initial protozoa inoculum was prepared by measuring an aliquot of the live suspension using photometry 
absorbance at 440 nm and diluted to achieve a theoretical OD value of 0.040. Each test cell is inoculated with 
40 µL of this suspension, lending to an approximate population density of 100 protozoa per milliliter.
An initial study was carried out to find the approximate range of uninhibited growth and 100% inhibition for 
each enantiomer/compound across 7 orders of magnitude. The definitive toxicity test was carried out from the 
lowest concentration with a percentage population growth inhibition of 80–100% to the highest concentration 
with an inhibition between 0–20%. To ensure the test was valid the control must reach 60% OD decrease after 
24 h. In some tests this may take 2–4 h longer than 24 h, this is batch dependent and indicates a slightly slower 
growth of the ciliates, however this is still considered valid. In this case all the tests carried out were with the same 
batch which took 28 h to fulfill the validation criteria. The EC50 values were calculated using 28 h results.
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